CCNC(=O)OCC1C2=C(C(=O)C(C)=C(N)C2=O)N2CC3C(N3C)C12OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?